| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $439.6M | — | +0.5% |
| Cost of Revenue | $330.0M | — | +4.1% |
| Gross Profit | $109.6M | — | -8.9% |
| R&D Expense | $16.2M | — | +14.4% |
| SG&A Expense | $58.7M | — | +14.8% |
| Operating Income | $31.9M | — | -35.7% |
| Pre-tax Income | $20.4M | — | +256.6% |
| Income Tax | $3.8M | — | -59.4% |
| Net Income | $16.5M | — | +173.4% |
| EPS (Basic) | $0.48 | — | +172.7% |
| EPS (Diluted) | $0.48 | — | +172.7% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.1M | -52.7% | -74.4% |
| Accounts Receivable | $327.8M | -5.3% | +18.7% |
| Inventory | $284.5M | +12.1% | +9.4% |
| Current Assets | $774.8M | +0.6% | +10.3% |
| Total Assets | $3.41B | +0.0% | +3.5% |
| Current Liabilities | $206.3M |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $24.7M | — | -21.0% |
| Capital Expenditures | $24.0M | — | -5.0% |
| Investing Cash Flow | -$37.9M | — | +80.8% |
| Financing Cash Flow | $3.8M | — | -97.5% |
| Free Cash Flow | $737K | — | -87.8% |
| -0.0% |
| Long-term Debt | $1.25B | +5.6% | +1.3% |
| Total Liabilities | $1.71B | +3.1% | +1.4% |
| Stockholders' Equity | $1.70B | -2.8% | +5.6% |